Background—In 1994, an International Task Force proposed criteria for the clinical
diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) that …

The writing committee consisted of acknowledged experts in the field of CMR, as well as a
liaison from the ACCF Task Force on Clinical ECDs, the oversight group for this document …

BACKGROUND: Prior reports on patients with arrhythmogenic right ventricular
cardiomyopathy/dysplasia (ARVC/D) focused on individuals with advanced forms of the …

There is growing attention for the study of the right ventricle in cardiovascular disease and in
particular in heart failure. In this clinical setting, right ventricle dysfunction is a significant …

Objectives: The purpose of our study was to assess the impact of revised versus original
criteria on the prevalence of arrhythmogenic right ventricular cardiomyopathy/dysplasia …

Arrhythmogenic right-ventricular dysplasia is a rare disease. Recent new findings
concerning the diagnosis and management of these patients should have direct implications …

OBJECTIVE. The purpose of this article is to present current clinical and research issues in
MRI evaluation of nonischemic cardiomyopathy, a diverse set of diseases, many of which …

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a potentially lethal disease that
is well described in adults. In pediatric patients, however, identification of patients at risk of …

Patients with non-ischemic cardiomyopathy often represent a diagnostic challenge, and
correct etiologic diagnosis may influence outcomes. Lately, delayed myocardial …

Cardiac magnetic resonance (CMR) has been helpful in adults in the diagnosis of
arrhythmogenic right ventricular dysplasia. Short of direct surgical observation or autopsy …